scholarly article | Q13442814 |
P356 | DOI | 10.1007/BF02088249 |
P698 | PubMed publication ID | 8654164 |
P50 | author | Wolfgang Stremmel | Q50772068 |
P2093 | author name string | T Goeser | |
L Theilmann | |||
M Mohler | |||
S Seipp | |||
U Tox | |||
P2860 | cites work | A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 |
Transient immunoglobulin M antibody response to hepatitis C virus capsid antigen in posttransfusion hepatitis C: putative serological marker for acute viral infection | Q33612002 | ||
Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis | Q39514969 | ||
Significance of IgM antibody to hepatitis C virus in patients with chronic hepatitis C | Q41836952 | ||
Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. | Q50878460 | ||
Immunomodulatory effects of ursodeoxycholic acid on immune responses | Q68225187 | ||
Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid | Q68925952 | ||
Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trial | Q72347760 | ||
The effect of ursodeoxycholic acid on serum enzymes and liver histology in patients with chronic active hepatitis. A 12-month double-blind, placebo-controlled trial | Q72682269 | ||
P433 | issue | 6 | |
P304 | page(s) | 1276-1277 | |
P577 | publication date | 1996-06-01 | |
P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
P1476 | title | Effect of ursodeoxycholic acid on HCV replication in subtyped chronic hepatitis C | |
P478 | volume | 41 |
Q73562590 | Long-term efficacy of interferon-alpha and ursodeoxycholic acid in treatment of chronic type C hepatitis | cites work | P2860 |
Search more.